@article{684560fd47674497bd7dcb5b923daa88,
title = "The start-ups taking nanoneedles into the clinic",
author = "Roey Elnathan and Andy Tay and Voelcker, {Nicolas H.} and Ciro Chiappini",
note = "Funding Information: Cytosurge sold its unique atomic force microscopy hollow probe right from the early stages. Behr says Cytosurge had a profitable margin from the start, allowing them to operate at a small scale for several years. Then Cytosurge accessed Swiss National Science Foundation funding, which enabled ETH Z{\"u}rich and the company to share PhD students. This was important in developing FluidFM at reasonable cost. Cytosurge{\textquoteright}s initial idea was to manufacture only hollow FluidFM nanoprobes, but at a certain stage they made the decision to design their own atomic force microscopy instruments, decoupling from external tool manufacture to exercise closer control over the process. Cytosurge technology was so versatile and disruptive that it gave birth to another spin-off, Exaddon, which now specializes in three-dimensional electrochemical metal microprinting. Funding Information: A.T. would like to acknowledge the support of the NUS Presidential Young Professorship, MOE Tier 1 grant and NMRC OF-YIRG.CC acknowledges funding from the European Research Council Starting Grant (ENBION 759577) and the Medical Research Council (MC_PC_16048). R.E. would like to acknowledge that this work was in part funded by the Australian Government (ARC DECRA project number: DE170100021); R.E., N.H.V. acknowledge the ARC Training Centre for Cell & Tissue Engineering Technologies (IC190100026). ",
year = "2022",
month = aug,
doi = "10.1038/s41565-022-01158-5",
language = "English",
volume = "17",
pages = "807--811",
journal = "Nature Nanotechnology",
issn = "1748-3387",
publisher = "Nature Publishing Group",
number = "8",
}